Demand for large volume wearable injectors will increase through 2036, with on-body injectors at a 38.0% share in 2026 as the leading product segment. The market is expected to reach USD 3.94 billion in 2026 and USD 9.24 billion by 2036, creating an absolute opportunity of USD 5.30 billion.